跳至主要内容
临床试验/NCT01934088
NCT01934088已完成4 期

Nurse Administered Propofol Sedation vs. Standard Therapy for Colonoscopy in Patients With IBD. A Randomised Controlled Study on Satisfaction and Adherence to Treatment Program.

Copenhagen University Hospital at Herlev1 个研究点 分布在 1 个国家目标入组 130 人开始时间: 2014年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
130
试验地点
1
主要终点
Satisfaction

研究概览

简要总结

Sedation for endoscopy is a service more than a necessity. Therefore it should be patient driven. Patients with inflammatory bowel disease (IBD) undergoes life long endoscopic control. Therefore, satisfaction with the procedure experience is paramount for patients with IBD. Investigators wish to study the feasibility and the effect on patient experience of two drugs. Propofol administered by endoscopy nurses (NAPS) and conventional therapy with a combination of fentanyl and midazolam. Investigators hypothesize that patients sedated with propofol has a better procedure experience, that a well performed sedation equals a better experience and that NAPS is as feasible as fentanyl with midazolam sedation.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Inflammatory Bowel Disease (IBD) or suspected IBD
  • Planned Endoscopy
  • Candidate for propofol sedation
  • willingness to be randomized
  • Ability to complete questionnaire

排除标准

  • Allergy to drugs
  • American Society of Anesthesiologists Class III
  • Body Mass Index > 35
  • Ventricular retention
  • Acute condition
  • Severe Chronic obstructive pulmonary disease
  • Sleep apnea
  • Potentially difficult airway or previous difficulty with anesthesia
  • Pregnancy
  • <18 years

研究组 & 干预措施

Propofol

Experimental

Propofol in refract doses. Induction: 10-60 mg supplemented with 10-30 mg following an age correlated algorithm. Maintenance with refract bolus of 10-20 mg every 1-2 minutes after assessed need and condition

干预措施: Propofol (Drug)

Fentanyl and Midazolam

Active Comparator

0.025-0.05 mg of Fentanyl i.v. minimum 5 minutes before procedure as a single shot. Midazolam 1-2 mg i.v. for induction and 0.5-1 mg i.v. for maintenance after assessing needs and condition

干预措施: Midazolam (Drug)

Fentanyl and Midazolam

Active Comparator

0.025-0.05 mg of Fentanyl i.v. minimum 5 minutes before procedure as a single shot. Midazolam 1-2 mg i.v. for induction and 0.5-1 mg i.v. for maintenance after assessing needs and condition

干预措施: Fentanyl (Drug)

结局指标

主要结局

Satisfaction

时间窗: Participants will be interviewed when an Aldrete recovery score of 12 is achieved, an expected average of 2 hours after admission

Satisfaction points in a post procedure questionnaire.

次要结局

  • Pre-disposing factors for satisfaction with procedure and sedation(At admission to the hospital at time 0)

研究者

发起方
Copenhagen University Hospital at Herlev
申办方类型
Other
责任方
Principal Investigator
主要研究者

Jeppe Thue Jensen

MD

Copenhagen University Hospital at Herlev

研究点 (1)

Loading locations...

相似试验